Universal Influenza Vaccine Technology Landscape

The Landscape is a database of novel vaccine candidates designed to provide broader and more durable protection against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. CIDRAP is developing the landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development.

Provide Feedback

Learn More

Database last updated on Feb 21, 2024

Tracker

Vaccine Candidates 197 Vaccine Candidates
Vaccine in clinical trials 39 Vaccines in Clinical Trials
COVID+Flu Vaccine Candidates 4 COVID+Flu Vaccine Candidates
Developers 154 Developers
Platforms 6 Platforms
Preclinical 158
Phase 1 16
Phase 2 16
Phase 3 7
Approved 0

Database

Previous Next
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Platform

Influenza virus-based

14
Vaccines in
Preclinical
2
Vaccines in
Phase 1
3
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Nucleic acid-based

22
Vaccines in
Preclinical
6
Vaccines in
Phase 1
5
Vaccines in
Phase 2
4
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Non-VLP nanoparticles

37
Vaccines in
Preclinical
4
Vaccines in
Phase 1
2
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Recombinant proteins

37
Vaccines in
Preclinical
0
Vaccines in
Phase 1
3
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved